Mike Kelly is the President & Chief Executive Officer of NervGen Pharma, a clinical-stage biotech company focused on developing innovative treatments.
Mike Kelly is the President & Chief Executive Officer of NervGen Pharma, a clinical-stage biotech company focused on developing innovative treatments for nervous system repair. He has three decades of pharmaceutical experience and has played instrumental roles in the creation, development, and strengthening of several companies.
Full founder directory · Investor directory · Company funding database · Fundraising library